Noho, Inc. Receivables Turnover Ratio (DRNK), from the third quarter 2014 to the third quarter 2013 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Noho, Inc.  (DRNK)
 

Noho Accounts Receivables Turnover Ratio from the third quarter 2014 to the third quarter 2013

Quarterly Results, Trends, Rankings, Statistics


Noho, Inc.'s ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2014 to a ratio of 11.83, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Noho in Sep 30 2014 quarter, has decreased to 31 days, compared to 35 days, in the Jun 30 2014 quarter.

If we take a look into Healthcare sector 51 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2014 from 131 to 921.

What is Receivable Turnover Ratio?
What is Noho, Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DRNK Receivables Turnover Ratio (Sep 30 2014)
III. Quarter		 (Jun 30 2014)
II. Quarter		 (Mar 31 2014)
I. Quarter		 (Dec 31 2013)
IV. Quarter		 (Sep 30 2013)
III. Quarter
Y / Y Receivable Change -11.2 % 311.45 % -59.82 % - -
Y / Y Revenue Change 65.54 % 182.64 % -39.78 % - -
Receivable Turnover Ratio (TTM) 11.83 10.56 14.72 10.59 6.44
DRNK's Total Ranking # 921 # 131 # 921 # 0 # 0
Accounts Receivable average collection period days 31 35 25 34 57
Seq. Receivable Change -79.71 % 147.6 % 73.48 % 1.91 % -6.01 %
Seq. Revenue Change -0.84 % 92.95 % -68.41 % 173.87 % 69.3 %


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 5
Healthcare Sector # 52
Overall Market # 921

Receivable Turnover Ratio Statistics
High Average Low
14.72 12.37 10.56
(Mar 31 2014)   (Jun 30 2014)





DRNK Company Profile • Back to DRNK Efficiency Comparisons • Compare DRNK Receivables Turnover Ratio to its Competitors

Financial Statements
Noho's Accounts Receivable $ 0 Millions Visit DRNK's Balance sheet
Noho's Sales TTM $ 1 Millions Visit DRNK's Income Statement
Sources of DRNK's Revenues Visit DRNK's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
DRNK's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
DRNK's Growth Rates DRNK's Roa DRNK's Inventory Turnover Ratio DRNK's Dividend Comparisons
DRNK's Profitability Ratios DRNK's Roi DRNK's Asset Turnover Ratio DRNK's Dividend Growth
DRNK's Valuation Ratios DRNK's Roe DRNK's Financial Strength Ratios DRNK's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2014, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2014 Receivable at quarter ending Sep 30 2014
Innoviva Inc   70.71 $ 3.571  Millions$ 0.051  Millions
Acadia Pharmaceuticals Inc   60.31 $ 37.073  Millions$ 0.615  Millions
Cytokinetics Incorporated  54.56 $ 49.531  Millions$ 0.908  Millions
Lifevantage Corp  53.20 $ 214.273  Millions$ 4.028  Millions
Windtree Therapeutics Inc  53.08 $ 1.725  Millions$ 0.033  Millions
Ptc Therapeutics inc   52.47 $ 16.999  Millions$ 0.324  Millions
Oncomed Pharmaceuticals Inc  42.12 $ 50.028  Millions$ 1.188  Millions
Prothena Corporation Public Limited Company  40.33 $ 49.008  Millions$ 1.215  Millions
Sonida Senior Living Inc   36.02 $ 372.700  Millions$ 10.347  Millions
Alnylam Pharmaceuticals Inc   32.16 $ 39.272  Millions$ 1.221  Millions
Wearable Health Solutions, Inc.  30.64 $ 1.160  Millions$ 0.038  Millions
Seelos Therapeutics inc   30.43 $ 7.652  Millions$ 0.252  Millions
Brookdale Senior Living Inc   29.81 $ 3,313.836  Millions$ 111.172  Millions
Ernexa Therapeutics Inc   29.74 $ 25.871  Millions$ 0.870  Millions
Oragenics Inc   29.51 $ 1.154  Millions$ 0.039  Millions
American Cryostem Corporation  28.19 $ 0.121  Millions$ 0.004  Millions
Nature s Sunshine Products inc   27.97 $ 378.218  Millions$ 13.522  Millions
Veracyte Inc   26.56 $ 32.829  Millions$ 1.236  Millions
Cyteir Therapeutics Inc   25.45 $ 2,002.800  Millions$ 78.700  Millions
Cba Florida Inc   23.68 $ 5.696  Millions$ 0.241  Millions
Harrow Inc   23.15 $ 1.113  Millions$ 0.048  Millions
Macrogenics Inc   19.55 $ 57.227  Millions$ 2.927  Millions
Sunlink Health Systems Inc   19.37 $ 105.047  Millions$ 5.423  Millions
Intelgenx Technologies Corp   17.96 $ 1.235  Millions$ 0.069  Millions
U s Stem Cell Inc   17.93 $ 1.471  Millions$ 0.082  Millions
Vanda Pharmaceuticals Inc   17.79 $ 43.570  Millions$ 2.449  Millions
Oncologix Tech Inc.  17.77 $ 3.677  Millions$ 0.207  Millions
Gt Biopharma Inc   17.60 $ 0.330  Millions$ 0.019  Millions
Abeona Therapeutics Inc   17.59 $ 0.853  Millions$ 0.049  Millions
Statera Biopharma Inc fka Cytocom Inc   17.16 $ 6.183  Millions$ 0.360  Millions

Date modified: 2026-06-22T14:31:53+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.